Legal Representation
Attorney
Robert M. Collins
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 3, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 3, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 21, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| May 21, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| May 21, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Mar 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 12, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 12, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 27, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 27, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 27, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 12, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Dec 12, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Sep 12, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 12, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 12, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 21, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 28, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Sale of medical grade plasma by way of direct contracts or through brokers to pharmaceutical companies for use in the production of plasma protein based therapies
First Use Anywhere:
Jun 23, 2021
First Use in Commerce:
Jun 23, 2021
Class 044
Collection of medical grade source blood plasma for use in the production of plasma protein based therapies
First Use Anywhere:
Jun 23, 2021
First Use in Commerce:
Jun 23, 2021
Classification
International Classes
035
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
PLASMA